- Home
- Automated
- List of product information
- ROZEX GEL 0.75% [SIN08453P]
ROZEX GEL 0.75% [SIN08453P]
Active ingredients: ROZEX GEL 0.75%
Product Info
ROZEX GEL 0.75%
[SIN08453P]
Product information
Active Ingredient and Strength | METRONIDAZOLE - 0.75% |
Dosage Form | GEL |
Manufacturer and Country | LABORATOIRES GALDERMA - FRANCE |
Registration Number | SIN08453P |
Licence Holder | GALDERMA SINGAPORE PRIVATE LIMITED |
Forensic Classification | PRESCRIPTION ONLY MEDICINES |
Anatomical Therapeutic Chemical (ATC) code | D06BX01 |
INDICATIONS AND USAGE
ROZEX Gel is indicated for topical application in the treatment of inflammatory papules, pustules and erythema of rosacea.
DOSAGE AND ADMINISTRATION
Apply and rub in a thin film of ROZEX twice daily, morning and evening, to the entire affected areas after washing. Significant therapeutic results should be noticed within three weeks. Clinical studies have demonstrated continuing improvement through nine weeks of therapy. Areas to be treated should be cleansed before application of ROZEX. Patients may use cosmetics after application of ROZEX.
CONTRA-INDICATIONS
Rozex Gel is contraindicated in individuals with a history of hypersensitivity to metronidazole, parabens, or other Ingredients of the formulation.
